ISABEL CANO FERRI

Instituto de Investigación Sanitaria La Fe

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

JAIME PEREZ DE OTEYZA

HEAD

SPAIN

View details

Rebeca Rodríguez-Veiga

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

María-Belén Vidriales

Universidad de Salamanca

SPAIN

View details

Garcia-Foncillas J

Full Professor

Universidad Autónoma de Madrid

SPAIN

View details

Miguel Sanz

Full Professor - Honorary Professor

University of Valencia

SPAIN

View details

Miriam Saiz Rodríguez

Associate Professor

Universidad de Burgos

SPAIN

View details

Josep Maria Ribera Santasusana

Chief of the Department

Institut Català d'Oncologia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ISABEL CANO FERRI

Research Interests

Explore related searches

Contact this professor

Articles (10)

Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results

Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups

A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX.

Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study.

Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia

Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis

Collaborators (7)

JAIME PEREZ DE OTEYZA

Rebeca Rodríguez-Veiga

María-Belén Vidriales

Garcia-Foncillas J

Miguel Sanz

Miriam Saiz Rodríguez

Josep Maria Ribera Santasusana

Make your next move.

ISABEL CANO FERRI

Research Interests

Explore related searches

Contact this professor

Articles (10)

Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results

Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups

A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX.

Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study.

Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

Healthcare Resource Utilization among Patients between 60&ndash;75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia

Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis

Collaborators (7)

JAIME PEREZ DE OTEYZA

Rebeca Rodríguez-Veiga

María-Belén Vidriales

Garcia-Foncillas J

Miguel Sanz

Miriam Saiz Rodríguez

Josep Maria Ribera Santasusana

Make your next move.

Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study